期刊
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
卷 172, 期 1, 页码 67-71出版社
SPRINGER
DOI: 10.1007/s10517-021-05333-x
关键词
breast cancer; microRNA genes; methylation; metastasis prognosis
A systemic analysis was conducted to study the relationship between methylation levels of 21 microRNA genes and breast cancer progression, leading to the identification of significant associations for 11 genes with late clinical stages. A prediction marker system for metastasis was proposed based on 6 highly significant genes.ROC analysis showed that this system has an 87% sensitivity and 77% specificity, indicating potential clinical application in personalized treatment of breast cancer patients.
Systemic analysis of the relationship between the levels of methylation of 21 microRNA genes and the parameters of breast cancer progression was performed on a representative sample of 91 paired specimens of breast cancer and histologically normal tissues and a system of markers for prediction of metastasis was proposed. A significant association of hypermethylation of 11 genes with late (III-IV) clinical stages was found, and for 6 genes (MIR124-1, MIR127, MIR34B/C, MIR9-3, MIR1258, and MIR339) this association was highly significant (p <= 0.001, FDR=0.01). For MIR9-3 and MIR339, an association with tumor size was demonstrated (p<0.001, FDR=0.01). No association of the levels of methylation of the analyzed microRNA genes with the degree of differentiation were found. An association with lymph node metastasis was established for 9 microRNA genes; the most significant association was shown for 6 genes MIR125B-1, MIR127, MIR9-3, MIR339, MIR124-3, and MIR1258 (p<0.005, FDR=0.05). Based on these 6 genes, a marker system for predicting breast cancer metastasis was developed by ROC analysis. This system is characterized by 87% sensitivity and 77% specificity (AUC=0.894). The proposed system may have clinical application in the personalized treatment of breast cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据